Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

BENDROFLUMETHIAZIDE CRS (100 MG)

BENDROFLUMETHIAZIDE CRS (100 MG)

73-48-3

DISCOVER
BENPERIDOL CRS (100 MG)

BENPERIDOL CRS (100 MG)

2062-84-2

DISCOVER
BENSERAZIDE HYDROCHLORIDE CRS(50 MG)

BENSERAZIDE HYDROCHLORIDE CRS(50 MG)

14919-77-8

DISCOVER
BENSERAZIDE IMPURITY A CRS (15 MG)

BENSERAZIDE IMPURITY A CRS (15 MG)

NA

DISCOVER
BENZARONE CRS (10 MG)

BENZARONE CRS (10 MG)

1477-19-6

DISCOVER
BENZATHINE BENZYLPENICILLIN CRS (200 MG)

BENZATHINE BENZYLPENICILLIN CRS (200 MG)

1538-09-6

DISCOVER
BENZETHONIUM CHLORIDE CRS (100 MG)

BENZETHONIUM CHLORIDE CRS (100 MG)

ND

DISCOVER
Bromhexine HCL

Bromhexine HCL

611-75-6

DISCOVER
BENZOCAINE CRS (50 MG)

BENZOCAINE CRS (50 MG)

94-09-7

DISCOVER
HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM (N/A)

HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Bezafibrate

Bezafibrate

41859-67-0

DISCOVER
BENZYL BENZOATE - REFERENCE SPECTRUM (N/A)

BENZYL BENZOATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER